Caffeic acid on metabolic syndrome: A review
Metabolic syndrome (MetS) is a constellation of risk factors that may lead to a more sinister disease. Raised blood pressure, dyslipidemia in the form of elevated triglycerides and lowered highdensity lipoprotein cholesterol, raised fasting glucose, and central obesity are the risk factors that coul...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Molecular Diversity Preservation International
2021
|
Subjects: | |
Online Access: | https://eprints.ums.edu.my/id/eprint/42431/1/FULL%20TEXT.pdf |
_version_ | 1825716035979837440 |
---|---|
author | Nellysha Namela Muhammad Abdul Kadar Fairus Ahmad Seong, Lin Teoh Mohamad Fairuz Yahaya |
author_facet | Nellysha Namela Muhammad Abdul Kadar Fairus Ahmad Seong, Lin Teoh Mohamad Fairuz Yahaya |
author_sort | Nellysha Namela Muhammad Abdul Kadar |
collection | UMS |
description | Metabolic syndrome (MetS) is a constellation of risk factors that may lead to a more sinister disease. Raised blood pressure, dyslipidemia in the form of elevated triglycerides and lowered highdensity lipoprotein cholesterol, raised fasting glucose, and central obesity are the risk factors that could lead to full-blown diabetes, heart disease, and many others. With increasing sedentary lifestyles, coupled with the current COVID-19 pandemic, the numbers of people affected with MetS will be expected to grow in the coming years. While keeping these factors checked with the polypharmacy available currently, there is no single strategy that can halt or minimize the effect of MetS to patients. This opens the door for a more natural way of controlling the disease. Caffeic acid (CA) is a phytonutrient belonging to the flavonoids that can be found in abundance in plants, fruits, and vegetables. CA possesses a wide range of beneficial properties from antioxidant, immunomodulatory, antimicrobial, neuroprotective, antianxiolytic, antiproliferative, and anti-inflammatory activities. This review discusses the current discovery of the effect of CA against MetS. |
first_indexed | 2025-03-05T01:34:52Z |
format | Article |
id | ums.eprints-42431 |
institution | Universiti Malaysia Sabah |
language | English |
last_indexed | 2025-03-05T01:34:52Z |
publishDate | 2021 |
publisher | Molecular Diversity Preservation International |
record_format | dspace |
spelling | ums.eprints-424312024-12-30T01:34:42Z https://eprints.ums.edu.my/id/eprint/42431/ Caffeic acid on metabolic syndrome: A review Nellysha Namela Muhammad Abdul Kadar Fairus Ahmad Seong, Lin Teoh Mohamad Fairuz Yahaya RB151-214 Theories of disease. Etiology. Pathogenesis RC31-1245 Internal medicine Metabolic syndrome (MetS) is a constellation of risk factors that may lead to a more sinister disease. Raised blood pressure, dyslipidemia in the form of elevated triglycerides and lowered highdensity lipoprotein cholesterol, raised fasting glucose, and central obesity are the risk factors that could lead to full-blown diabetes, heart disease, and many others. With increasing sedentary lifestyles, coupled with the current COVID-19 pandemic, the numbers of people affected with MetS will be expected to grow in the coming years. While keeping these factors checked with the polypharmacy available currently, there is no single strategy that can halt or minimize the effect of MetS to patients. This opens the door for a more natural way of controlling the disease. Caffeic acid (CA) is a phytonutrient belonging to the flavonoids that can be found in abundance in plants, fruits, and vegetables. CA possesses a wide range of beneficial properties from antioxidant, immunomodulatory, antimicrobial, neuroprotective, antianxiolytic, antiproliferative, and anti-inflammatory activities. This review discusses the current discovery of the effect of CA against MetS. Molecular Diversity Preservation International 2021 Article NonPeerReviewed text en https://eprints.ums.edu.my/id/eprint/42431/1/FULL%20TEXT.pdf Nellysha Namela Muhammad Abdul Kadar and Fairus Ahmad and Seong, Lin Teoh and Mohamad Fairuz Yahaya (2021) Caffeic acid on metabolic syndrome: A review. Molecules, 26. pp. 1-14. https://doi.org/10.3390/molecules26185490 |
spellingShingle | RB151-214 Theories of disease. Etiology. Pathogenesis RC31-1245 Internal medicine Nellysha Namela Muhammad Abdul Kadar Fairus Ahmad Seong, Lin Teoh Mohamad Fairuz Yahaya Caffeic acid on metabolic syndrome: A review |
title | Caffeic acid on metabolic syndrome: A review |
title_full | Caffeic acid on metabolic syndrome: A review |
title_fullStr | Caffeic acid on metabolic syndrome: A review |
title_full_unstemmed | Caffeic acid on metabolic syndrome: A review |
title_short | Caffeic acid on metabolic syndrome: A review |
title_sort | caffeic acid on metabolic syndrome a review |
topic | RB151-214 Theories of disease. Etiology. Pathogenesis RC31-1245 Internal medicine |
url | https://eprints.ums.edu.my/id/eprint/42431/1/FULL%20TEXT.pdf |
work_keys_str_mv | AT nellyshanamelamuhammadabdulkadar caffeicacidonmetabolicsyndromeareview AT fairusahmad caffeicacidonmetabolicsyndromeareview AT seonglinteoh caffeicacidonmetabolicsyndromeareview AT mohamadfairuzyahaya caffeicacidonmetabolicsyndromeareview |